Salvage brachytherapy for local recurrence after radical prostatectomy and subsequent external beam radiotherapy

Urology

Volumn 62, Issue 6, 2003, Pages 1068-1072

  Losa, Andrea ^a   Nava, Luciano Dante ^a   Di Muzio, Nadia ^a   Mangili, Paola ^a   Longobardi, Barbara ^a   Rigatti, Patrizio ^a   Guazzoni, Giorgio ^a  

^a Casa di Cura Ville Turro ^*

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 125; PALLADIUM 103; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BEAM THERAPY; BRACHYTHERAPY; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSIMETRY; EVALUATION; FOLLOW UP; HEMATURIA; HUMAN; INCONTINENCE; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATECTOMY; RADIATION DOSE; SALVAGE THERAPY;

EID: 0345528217     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(03)00784-2     Document Type: Article

References (29)

1. Stephenson R. Population-based trends in the PSA-era data from the Surveillance, Epidemiology and End Results (SEER) program . Monogr Urol. 19:1998;1-19.
2. Catalona W.J., Smith D.S. 5-year tumor recurrence rates after anatomical radical retropubic prostatectomy for prostate cancer. J Urol. 152:1994;1837-1842.
3. Kupelian P.A., Katcher J., Levin H.S., et al. Stage T1-2 prostate cancer a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy . Int J Radiat Oncol Biol Phys. 37:1997;1043-1052.
4. Kalapurakal J.A., Huang C.F., Neriamparampil M.M., et al. Biochemical disease-free survival following adjuvant and salvage irradiation after radical prostatectomy. Int J Radiat Oncol Biol Phys. 54:2002;1047-1054.
5. Pound C.R., Partin A.W., Eisenberger M.A., et al. Natural history of progression after PSA elevation following radical prostatectomy. JAMA. 281:1999;1591-1597.
6. Song D.Y., Thompson T.L., Ramakrishnan V., et al. Salvage radiotherapy for rising or persistent PSA after radical prostatectomy. Urology. 60:2002;281-287.
7. Chin J.L., Pautler S.E., Mouraviev V., et al. Results of salvage cryoablation of the prostate after radiation identifying predictors of treatment failure and complications . J Urol. 165:2001;1937-1942.
8. Izawa J.I., Ajam K., McGuire E., et al. Major surgery to manage definitively severe complications of salvage cryotherapy for prostate cancer. J Urol. 164:2000;1978-1981.
9. Waxman S., Stevens A.K., Walsh R.A., et al. Management of asymptomatic rising PSA after prostatectomy or radiation therapy. Oncology (Huntingt). 11:1997;457-465.
10. Patel B.G., Parsons C.L., Bidair M., et al. Cryoablation for carcinoma of the prostate. J Surg Oncol. 63:1996;256-264.
11. Gleason D.F. Histologic grading and clinical staging of prostatic carcinoma. Tannenbaum M. Urologic Pathology The Prostate . 1977;171-198 Lea & Febinger, Philadelphia.
12. Barry M.J., Fowler F.J. Jr, O'Leary M.P., et al. The American Urological Association symptom index for benign prostatic hyperplasia. J Urol. 148:1992;1549-1557.
13. Cox J.D., Stetz J., Pajak T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 31:1995;1341-1346.
14. Holm H.H., Juul N., Pedersen J.F., et al. Transperineal 125 iodine seed implantation in prostatic cancer guided by transrectal ultrasonography. J Urol. 130:1983;283-286.
15. Nag S. Radioactive iodine-125 implantation for cancer of the prostate. Prostate. 6:1985;293-301.
16. Ragde H., Blasko J.C., Schumacher D. Use of transrectal ultrasound in transperineal iodine-125 seeding for prostate cancer methodology . J Endourol. 3:1989;209-218.
17. Anscher M.S., Clough R., Dodge R. Radiotherapy for a rising prostate-specific antigen after radical prostatectomy the first 10 years . Int J Radiat Oncol Biol Phys. 48:2000;369-375.
18. Cadeddu J.A., Partin A.W., DeWeese T.L., et al. Long-term results of radiation therapy for prostate cancer recurrence following radical prostatectomy. J Urol. 159:1998;173-178.
19. Pisansky T.M., Kozelsky T.F., Myers R.P., et al. Radiotherapy for isolated serum prostate specific antigen elevation after prostatectomy for prostate cancer. J Urol. 163:2000;845-850.
20. Toonkel LM: Brachytherapy as salvage treatment for locally recurrent prostate cancer following definitive external beam irradiation. Presented at the First Annual Advanced Prostate Brachytherapy Workshop, Seattle, May 15, 1998.
21. Grado G.L., Collins J.M., Kriegshauser J.S., et al. Salvage brachytherapy for localized prostate cancer after radiotherapy failure. Urology. 53:1999;2-10.
22. Beyer D.C. Permanent brachytherapy as salvage treatment for recurrent prostate cancer. Urology. 54:1999;880-883.
23. Garzotto M., Wajsman Z. Androgen deprivation with salvage surgery for radiorecurrent prostate cancer. J Urol. 159:1998;950-955.
24. Zincke H. Radical prostatectomy and exenterative procedures for local failure after radiotherapy with curative intent comparison of outcomes . J Urol. 147:1992;894-899.
25. D'Amico A. Analysis of the clinical utility of use of salvage brachytherapy in patients who have a rising PSA after definitive external beam radiation therapy. Urology. 54:1999;201-203.
26. Desai J., Stock R.G., Stone N.N., et al. Acute urinary morbidity following I-125 interstitial implantation of the prostate gland. Radiat Oncol Invest. 6:1998;135-141.
27. 125I prostate implantation. Int J Radiat Oncol Biol Phys. 47:2000;353-360.
28. Cox J.D., Gallagher M.J., Hammond E.H., et al. Consensus statements on radiation therapy of prostate cancer guidelines for prostate re-biopsy after radiation and for radiation therapy with rising prostate-specific antigen levels after radical prostatectomy . J Clin Oncol. 17:1999;1155-1163.
29. Schild S.E., Buskirk S.J., Wong W.W., et al. The use of radiotherapy for patients with isolated elevation of serum prostate specific antigen following radical prostatectomy. J Urol. 156:1996;1725-1729.